Kathy Hopinkah Hannan
CIK 1767813 · last filed 2026-05-29
Kathy Hopinkah Hannan is a corporate insider who has filed 21 SEC Form 4 insider transactions across 6 companies since 2019. The most recent filing, for OTIS, was dated May 29, 2026. Current disclosed insider exposure totals $361.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$361.0K
6
21
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTIS | Director | — | $70.75 | — | $0 | 7 | 2026-05-29 |
| DNA | Director | 15,003 | $7.89 | $118.4K | $0 | 1 | 2025-06-13 |
| NLYpI | Director | 9,535 | $25.45 | $242.7K | $0 | 6 | 2025-05-15 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 167,249 | $0.01 | $1.1K | $0 | 3 | 2024-06-14 |
| CRS | Director | — | $561.49 | — | $0 | 3 | 2023-10-12 |
| ANNALY CAPITAL MANAGEMENT INC (NLYpH.CL) Delisted | Director | 0 | — | — | $0 | 1 | 2019-05-24 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | OTIS | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | DNA | Exer (M) | +10,822 | $0 | EDGAR |
| 2025-05-16 | OTIS | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | NLYpI | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Mixed | +105,263 | $0 | EDGAR |
| 2024-05-17 | NLYpI | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | OTIS | Grant (A) | — | $0 | EDGAR |
| 2023-10-12 | CRS | Grant (A) | — | $0 | EDGAR |
| 2023-06-21 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | OTIS | Grant (A) | — | $0 | EDGAR |